Showing 2331-2340 of 3068 results for "".
- Evolus Resubmits BLA for DWP-450 Ahead of Schedulehttps://modernaesthetics.com/news/evolus-resubmits-bla-for-dwp-450-ahead-of-schedule/2472049/Evolus has resubmitted its Biologics License Application (BLA) for its lead product candidate, DWP-450 (prabotulinumtoxinA), to the FDA. The resubmission follows the receipt of a Complete Response Letter (“CRL”) from the FDA in May 2018 which necessita
- Bonti's Novel Neurotoxin Shows Promise in Early Study of Scar Reduction After Mohs Surgeryhttps://modernaesthetics.com/news/bontis-novel-neurotoxin-shows-promise-in-early-study-of-scar-reduction-after-mohs-surgery/2472052/Topline results from Bonti’s SHINE-1 Phase 2a clinical trial suggest that its novel neurotoxin is safe and likely effective for scar reduction following Mohs surgery. EB-001, the active ingredient in EB-001A, is a novel botulinum neurotoxin serotype E (BoNT/E) with a unique clinical
- With New Applicator, Cryolipolysis is an Option for Male Pseudogynecomastiahttps://modernaesthetics.com/news/withnew-applicator-cryolipolysis-is-an-option-for-male-pseudogynecomastia/2472059/Thanks to a conformable surface applicator, cryolipolysis can be a safe and effective way to treat male pseudogynecomastia, according to a recent
- Power of Two: AMSPA, IALA To Mergehttps://modernaesthetics.com/news/power-of-two-amspa-iala-to-merge/2472062/The American Med Spa Associatio
- RealSelf: Laser & Energy Report Identifies Key Trendshttps://modernaesthetics.com/news/realself-laser-energy-report-identifies-key-trends/2472067/Demand for fat reduction is at an all-time high, and interest in vaginal rejuvenation continues to surge. These are among key findings of the newly release RealSelf US Laser & Energy Report, released this week. First in a ne
- TempSure Vitalia from Cynosure Hits North American Markethttps://modernaesthetics.com/news/tempsure-vitalia-from-cynosure-hits-north-american-market/2472068/Hologic's Cynosure division has launched TempSure™ Vitalia in North America. TempSure Vitalia is an FDA-cleared and Health Canada-approved advanced radiofrequency treatment that delivers therapeutic heat to inter
- Alana Sine Appointed Chief Financial Officer at Merz North Americahttps://modernaesthetics.com/news/alana-sine-appointed-chief-financial-officer-at-merz-north-america/2472072/Merz North America has appointed Alana Sine to Chief Financial Officer (CFO), Merz North America. Ms. Sine has served as interim CFO since March 2018. Ms. Sine will lead the finance function for North America, overseeing financial report
- Modern Aesthetics® Announces New Tweet Chat Series -- #RealDealAestheticshttps://modernaesthetics.com/news/modern-aesthetics-announces-new-tweet-chat-series-realdealaesthetics/2472073/Modern Aesthetics® magazine is launching a new Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD. The first Tweet chat focuses on filler selection in a r
- Evolus Appoints Michael Mazen Jafar Chief Marketing Officerhttps://modernaesthetics.com/news/evolus-appoints-michael-mazen-jafar-chief-marketing-officer/2472075/Evolus, Inc. has expanded its management team with the appointment of Michael Mazen Jafar as Chief Marketing Officer. Mr. Jafar joins Evolus from Allergan where he most recently served as Vice President, Medical Aesthetics. At Allergan Mr. Jafar led the commercial launch of Juve
- Aesthetic Extenders Symposium Coming Soonhttps://modernaesthetics.com/news/aesthetic-extenders-symposium-coming-soon/2472076/The 2018 Aesthetic Extender Symposium, billed as an event fit for the whole family, will be held August 23 to 26 at the Boca Raton Resort and CLub in Boca Raton, FL. This "must-attend conference"